Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neoplasms
|
1644 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.942 | 52 | 2009 | 2019 | |||||
Glioma
|
353 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.800 | 1.000 | 49 | 2009 | 2019 | |||||
Glioblastoma
|
281 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.800 | 0.977 | 43 | 2010 | 2020 | |||||
Glioblastoma Multiforme
|
186 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.969 | 32 | 2009 | 2020 | |||||
Adult Glioblastoma
|
98 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 18 | 2011 | 2019 | |||||
Childhood Glioblastoma
|
98 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 18 | 2011 | 2019 | |||||
oligodendroglioma
|
21 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 15 | 2012 | 2019 | |||||
Well Differentiated Oligodendroglioma
|
22 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 15 | 2012 | 2019 | |||||
Astrocytoma
|
59 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.800 | 0.923 | 13 | 2009 | 2018 | |||||
Leukemia, Myelocytic, Acute
|
6892 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.760 | 0.923 | 13 | 2009 | 2019 | |||||
Anaplastic astrocytoma
|
12 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 11 | 2011 | 2020 | |||||
Brain Neoplasms
|
204 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.790 | 1.000 | 11 | 2010 | 2018 | |||||
Adult Oligodendroglioma
|
19 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.080 | 1.000 | 8 | 2012 | 2019 | |||||
Childhood Oligodendroglioma
|
19 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.080 | 1.000 | 8 | 2012 | 2019 | |||||
Malignant Neoplasms
|
1641 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.060 | 1.000 | 6 | 2012 | 2018 | |||||
Primary malignant neoplasm
|
1374 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.060 | 1.000 | 6 | 2012 | 2018 | |||||
Adult Anaplastic Astrocytoma
|
8 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.050 | 1.000 | 5 | 2014 | 2018 | |||||
Grade III Childhood Astrocytoma
|
8 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.050 | 1.000 | 5 | 2014 | 2018 | |||||
Malignant Glioma
|
22 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.050 | 1.000 | 5 | 2013 | 2017 | |||||
Tumor Cell Invasion
|
169 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.050 | 1.000 | 5 | 2014 | 2020 | |||||
Childhood Astrocytoma
|
39 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.040 | 0.750 | 4 | 2014 | 2018 | |||||
Diffuse Glioma
|
7 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.040 | 0.750 | 4 | 2012 | 2019 | |||||
Diffuse Astrocytoma
|
8 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2013 | 2018 | |||||
Glioblastoma, IDH-Mutant
|
4 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.030 | 0.667 | 3 | 2012 | 2018 | |||||
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED
|
32 | 0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2019 | 2019 |